These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35518784)

  • 1. LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis.
    Ding Y; Li Y; Duan Y; Wang W; Zheng W; Cheng W; Qi Y; Feng J; Chen Z; Yu T; Hu A; Wang T; Li M; Zhang H; Li Y; Ma F; Guo B
    J Oncol; 2022; 2022():9999343. PubMed ID: 35518784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.
    Su J; Chen D; Ruan Y; Tian Y; Lv K; Zhou X; Ying D; Lu Y
    Bioengineered; 2022 Mar; 13(3):6978-6995. PubMed ID: 35311623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of lncRNA MBNL1-AS1 Promotes Tumor Stem Cell-like Characteristics and Prostate Cancer Progression through miR-221-3p/CDKN1B/C-myc Axis.
    Liu J; Niraj M; Wang H; Zhang W; Wang R; Kadier A; Li W; Yao X
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression.
    Pan QH; Fan YH; Wang YZ; Li DM; Hu CE; Li RX
    J Biol Regul Homeost Agents; 2020; 34(3):795-805. PubMed ID: 32691576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCM3AP-AS1 regulates proliferation, apoptosis, migration, and invasion of breast cancer cells via binding with ZFP36.
    Tang TP; Qin CX; Yu H
    Transl Cancer Res; 2021 Oct; 10(10):4478-4488. PubMed ID: 35116304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p.
    Zhu K; Wang Y; Liu L; Li S; Yu W
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):101-114. PubMed ID: 31255531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis.
    Fang J; Jiang G; Mao W; Huang L; Huang C; Wang S; Xue H; Ke J; Ni Q
    Bioengineered; 2022 Feb; 13(2):3707-3723. PubMed ID: 35094653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ADAMTS9-AS1 Restrains the Aggressive Traits of Breast Carcinoma Cells via Sponging miR-513a-5p.
    Fang S; Zhao Y; Hu X
    Cancer Manag Res; 2020; 12():10693-10703. PubMed ID: 33149676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.
    Xu L; Zhu S; Tang A; Liu W
    Inflamm Res; 2021 Feb; 70(2):217-227. PubMed ID: 33454803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
    Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
    Onco Targets Ther; 2020; 13():11277-11288. PubMed ID: 33177836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA IGBP1-AS1/miR-24-1/ZIC3 loop regulates the proliferation and invasion ability in breast cancer.
    Chen D; Fan Y; Wan F
    Cancer Cell Int; 2020; 20():153. PubMed ID: 32390766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
    Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
    Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing lncRNA CDKN2B-AS1 Alleviates Childhood Asthma Progression Through Inhibiting ZFP36 Promoter Methylation and Promoting NR4A1 Expression.
    Chen Z; Fan N; Shen G; Yang J
    Inflammation; 2023 Apr; 46(2):700-717. PubMed ID: 36422840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancer.
    Pan Z; Ding J; Yang Z; Li H; Ding H; Chen Q
    Cancer Cell Int; 2020; 20():214. PubMed ID: 32518523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.